Amneal Pharmaceuticals Inc (AMRX)

7.92 +0.09 (+1.15%) USD  |  NASDAQ  |  Dec 31, 16:00
7.925 0.00 (0.00%) After-Hours: 20:00
More

Amneal Pharmaceuticals Research and Development Expense (Quarterly): 63.06M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Edwards Lifesciences Corp 253.40M
KORU Medical Systems Inc 1.534M
Eyenovia Inc 3.472M
NovaBay Pharmaceuticals Inc 0.004M
Palatin Technologies Inc 5.744M